A clinical trial nurse is helping to register a patient to a phase II double-blind trial comparing a new medication to a placebo. Which of the following would the nurse include in the patient teaching? (Select all that apply.)

Question

Quizplus · Accepted Answer

A) It is important to inform the patient that the trial is double-blind, meaning that neither the patient nor the healthcare providers will know if the patient is receiving the real medication or a placebo. This is done to reduce bias and ensure that the results of the study are accurate.
B) Randomization is also important in ensuring that the study results are accurate, as it helps to eliminate potential confounding factors that may lead to biased results. 
C) It is important for the patient to understand that the goal of the trial is to determine if the new drug is effective in treating the condition it is intended for. This helps the patient understand why the trial is being conducted and what the expected outcome is. 
D) The number of participants in the trial is not as important for the patient to know, as it does not impact their participation in the study. 
E) The length of time it will take to obtain results is not as important for the patient to know, as they will not be actively involved in the trial for the entire duration.

A Clinical Trial Nurse Is Helping to Register a Patient